Background

Michael completed a Bachelor of Arts and Bachelor of Social Work (Honours) at Monash University in 2011 and worked in adult intensive case management, homelessness, and youth out-of-home care. Michael joined Burnet Institute as a research assistant in 2014, working primarily on alcohol and other drug and justice-related cohort studies.

Michael commenced as a PhD Student in the Justice Health and Alcohol and Other Drugs groups in 2019 under the supervision of Professors Mark Stoové and Paul Dietze. His research is investigating how the use of opioid substitution therapy during incarceration and post-release influences substance use, health and mortality outcomes among people who inject drugs.

Qualifications

• 2012: Bachelor of Arts/Bachelor of Social Work (Hon) – Monash University, Victoria, Australia

Awards

• 2019: Monash Addiction Research Centre PhD top-up scholarship
• 2012: Peter Boss Prize – Highest final year aggregate mark for Bachelor of Social Work (Hon) program

Projects (8)

Current (5)

• 

  Breaking the cycle: supporting people with drug use histories to avoid reincarceration

• 

  Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

• 

  IDRS: Illicit Drug Reporting System

• 

  Needle and Syringe Program (NSP) Snapshot Study

• 

  SuperMIX: The Melbourne Injecting Drug User Cohort Study

Past (1)

• 

  PATH Cohort Study

Publications (9)

2021 (3)

• Integrating episodes of imprisonment and the cascade of care for opioid use disorder.
  Cossar R, Stewart A, Winter R, Curtis M, Dietze P, Ogloff JRP, Stoové M
  Addiction. 2021 Jan; Epub ahead of print
• ‘Not my child’: parenting, pornography, and views on education.
  Davis AC, Wright C, Curtis M, Hellard ME, Lim MSC, Temple-Smith MJ
  J Fam Studies. 2021 Jan; Epub ahead of print
• Initiation of medications for opioid use disorder shortly before release from prison to promote treatment retention: Strong evidence but compromised policy.
  Curtis M, Larney S, Higgs P, Cossar RD, Winter RJ, Stewart AC, Stoové M
  J Addict Med. 2021 Jan; Epub ahead of print

2019 (2)

• Prison-based harm reduction measures as part of hepatitis C virus treatment.
  Curtis M, Higgs P, Stoové M
  Lancet Gastroenterol Hepatol. 2019 Dec; 4(12):903
• The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
  Kirwan A, Curtis M, Dietze P, Aitken C, Woods E, Walker S, Kinner S, Ogloff J, Butler T, Stoové M
  J Urban Health. 2019 Apr; 96(3):400-410

2018 (3)

• Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use.
  Stewart AC, Cossar R, Dietze P, Armstrong G, Curtis M, Kinner SA, Ogloff JRP, Kirwan A, Stoové M
  Health Justice. 2018 Oct; 6(1):19
• Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
  Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M
  Harm Reduct J. 2018 Sep; 15(1):48
• The associations of poor psychiatric well-being among incarcerated men with injecting drug use histories in Victoria, Australia.
  Cossar R, Stoové M, Kinner SA, Dietze P, Aitken C, Curtis M, Kirwan A, Ogloff JRP
  Health Justice. 2018 Jan; 6(1):1

2016 (1)

• Take-home naloxone programs and calls to emergency services.
  Kirwan A, Curtis M, van Beek IA, Cantwell K, Dietze PM
  Med J Aust. 2016 Mar; 204(4):143

News Articles (1)

2018 (1)

• NHMRC grants for Burnet research